For example, TCF12 expedites hepatocellular carcinoma (HCC) by upregulating CXCR4 and its ligand CXCL12 and activating the MAPK/ERK and PI3K/AKT pathways [30]. This evidence concerns the gene CXCR4 and hepatocellular carcinoma.